5-HT1B/1D antagonists and depression

Author: Halazy S.   Lamothe M.   Jorand-Lebrun C.  

Publisher: Informa Healthcare

ISSN: 1354-3776

Source: Expert Opinion on Therapeutic Patents, Vol.7, Iss.4, 1997-04, pp. : 339-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The molecular pharmacology, functional role and behavioural implications of central 5-HT1B/1D receptors suggest that these particular receptor subtypes probably play an important role in brain serotonin neurotransmission. This article summarises the rationale for considering 5-HT1B/1D antagonists as potential new, fast-acting antidepressants and describes the development of recent selective potent 5-HT1B/1D antagonists, reviewing both the primary and patent literature.